Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence DVSSALDKLKEFGNTLEDKARELIS
Primary information
sequence IDSeq_1609
Peptide sequenceDVSSALDKLKEFGNTLEDKARELIS
CancerPDF_ID CancerPDF_ID84, CancerPDF_ID1082,
PMID16896061,16395409
Protein NameApolipoprotein C-I,Apolipoprotein C-I
UniprotKB Entry NameAPOA4_HUMAN,APOC1_HUMAN
FluidSerum,Serum
M/Z2778.15,2778.15
Charge1,1
Mass (in Da)2778.44,NA
fdrNA,NA
Profiling TechniqueMALDI-TOF,MALDI-TOF
Peptide Identification techniqueQ/TOF MS/MS,Q/TOF/TOF and LC-MS/MS
Quantification TechniqueNA,NA
Labelled/Label FreeLabel Free,Label Free
FDRNA,less than 1 “5
CancerPDF_ID CancerPDF_ID84, CancerPDF_ID1082,
p-Value1.00E-05,NA
SoftwareMASCOT,MASCOT (v 2.0.04 for Windows)
Length25,25
Cancer TypeMetastatic thyroid carcinomas,"Advanced Prostate, Breast and Bladder cancer"
DatabaseNCBI refseq Protein Database,NCBI refseq Protein Database
ModificationNA,NA
Number of Patients40 metastatic thyroid carcinoma patients and 40 normal for training phase and 10 metastatic thyroid carcinoma and 10 normal individuals for independent validation,"Advanced prostate (n = 32), breast (n = 21), and bladder (n = 20) cancer, 33 healthy in training test set, In validation set 41 independent serum samples from patients with advanced prostate cancer (prostate 2 [PR2])"
RegulationNA,NA
ValidationIndependent validation,Independent validation
Sensitivity95% on independent dataset,97.5% on independent validation dataset
Specificity95% on independent dataset,NA
AccuracyNA,97.5 % on validation dataset
Peptide AtlasNA
IEDB